Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocept Inc
(NQ:
BIOC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biocept Inc
< Previous
1
2
3
Next >
Biocept Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
July 20, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Participate in Two July Investment Conferences
July 19, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
July 06, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Joins the Russell Microcap® Index
June 28, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
June 22, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service
June 15, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept and CLEARED4 Collaborate to Develop New Service for Managing COVID-19 Testing and Results Reporting for Biocept Customers
June 09, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Present at the LD Micro Virtual Invitational XI Conference on June 9, 2021
June 03, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Reports First Quarter 2021 Financial Results
May 12, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021
May 05, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept to Supply COVID-19 Testing Through Partnership With the Foundation for California Community Colleges
April 28, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Announces Full Commercial Launch of CNSide™ Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Cancer
April 21, 2021
From
Biocept, Inc.
Via
Business Wire
Biocept Provides Update on COVID-19 Testing with More than 350,000 Samples Received to Date
April 14, 2021
From
Biocept
Via
Business Wire
Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
April 07, 2021
From
Biocept, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.